KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Prehospital Resuscitation with Type O Whole Blood for Trauma and Hemorrhage.

Jason L Sperry, Francis X Guyette, Bryan A Cotton, James F Luther, Richard B Utarnachitt, Matthew E Kutcher, Brian J Daley, Allan B Peetz, Mayur B Patel, Michael D Goodman, Jeffrey A Claridge, Nimitt Patel, Brian G Harbrecht, Zain G Hashmi, Ryan Zarychanski, Matthew D Neal, Mark H Yazer, Christian Martin-Gill, Laura E Vincent, Ashley M Harner, David E Meyer, Andrew J Latimer, Bryce R Robinson, Catherine L McKnight, William R Hinckley, Keith R Miller, Jan O Jansen, Douglas Martin, Erin E Fox, Bedda L Rosario-Rivera, Stephen R Wisniewski, TOWAR Study Group

N Engl J Med 394(23) 2317-2328

PMID42150044
PMCIDPMC13313084
DOI10.1056/NEJMoa2602167
发表日期2026-05-18
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:Figure 1.:AI 判定为 flow diagram;Figure 2.:CONSORT/入组流程图;Figure 3.:CONSORT/入组流程图。
摘要

摘要

BACKGROUND: Blood transfusion before arrival at a hospital reduces mortality from traumatic hemorrhage and shock. Whether transfusion with whole blood is more beneficial than transfusion with blood components is uncertain, as are the effects of the length of time that blood products are in storage between donation and transfusion. METHODS: In this pragmatic, multicenter, phase 3, cluster-randomized trial, we assigned 44 air medical bases in a 2:1 ratio to the use of up to 2 units of whole blood or as-indicated blood components (plasma, red cells, or both) for prehospital transfusion in trauma patients during 1-month blocks. The primary outcome was death from any cause within 30 days after randomization. An observational substudy assessed outcomes according to the storage age of whole blood. RESULTS: Of 1020 eligible patients transported to hospitals by the air bases, 715 were assigned to receive whole blood and 305 to receive blood components; 695 and 298, respectively, were included in the primary analysis. Mortality at 30 days was 25.9% in the whole-blood group and 20.5% in the component group (adjusted odds ratio, 1.24; 95% confidence interval [CI], 0.87 to 1.76; P = 0.24). No substantial between-group differences in adverse events were observed. In the observational substudy, 30-day mortality was 27.1% among 210 patients who received whole blood with a storage age of 15 to 21 days and 26.4% among 443 patients who received whole blood with a storage age of 1 to 14 days (adjusted odds ratio, 0.99; 95% CI, 0.74 to 1.32). CONCLUSIONS: In injured patients with hemorrhagic shock, the use of whole blood for prehospital transfusion did not result in lower 30-day mortality than the use of blood components. (Funded by the Defense Health Agency Research Technology Portfolio Management, Combat Casualty Portfolio; TOWAR ClinicalTrials.gov number, NCT04684719.).

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(3,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1.Screening, Randomization, and Analysis
非 KM Figure
Figure 2.Survival and Subgroup Analyses of Mortality at 30 Days by Treatment Group. Panel A shows Kaplan–Meier estimates of survival among patients who were assigned to whole blood resuscitation or component blood resuscitation in the prehospital setting. Time zero was defined as arrival at a participating TOWAR site. Panel B shows the odds ratio of 30-day mortality across seven prespecified subgroups. The solid vertical line represents an odds ratio of 1.0, indicating no difference in mortality between the whole-blood group and the component-therapy group. Estimates are derived from logistic regression models with 30-day mortality as the outcome, including treatment-by-subgroup interaction terms. All models were adjusted for traumatic brain injury, prehospital intubation, and month of enrollment as fixed effects, with random intercepts and random slopes for air-medical base. Non-White race included Asian, Black or African American, American Indian or Alaska Native, and Other. Owing to small numbers of patients and/or events and model convergence limitations, some study sites were combined.
非 KM Figure
Figure 3.Survival and Subgroup Analyses of Mortality at 30 Days by Age of Whole Blood. Panel A shows Kaplan–Meier estimates of survival among patients who were assigned to whole blood resuscitation or component blood resuscitation in the prehospital setting. Time zero was defined as arrival at a participating TOWAR site. Panel B shows the odds ratio of 30-day mortality across seven prespecified subgroups. The solid vertical line represents an odds ratio of 1.0, indicating no difference in mortality between the whole-blood group and the component-therapy group. Estimates are derived from logistic regression models with 30-day mortality as the outcome, including treatment-by-subgroup interaction terms. All models were adjusted for month of enrollment (fixed effect), air-medical base (random effect to account for clustering), and inverse probability of treatment weighting (IPTW). Non-White race included Asian, Black or African American, American Indian or Alaska Native, and Other. Owing to small numbers of patients and/or events and model convergence limitations, some study sites were combined.
非 KM Figure